HZZO Razmatra Uvrštavanje Terapije Za Djecu Leptire Na Listu Lijekova
4 Articles
4 Articles
Povjerenstvo za lijekove Hrvatskog zavoda za zdravstveno osiguranje (HZZO) razmatrat će u utorak, 10. studenoga, zahtjev za uvrštavanje genske terapije za liječenje djece leptira na listu lijekova HZZO-a, za čiju dostupnost postoji velik interes javnosti, priopćeno je u […] Objava HZZO razmatra uvrštavanje terapije za djecu leptire na listu lijekova pojavila se prvi puta na Novi list.
The Croatian Institute of Health Insurance (HZZO) is deciding on including a new gene therapy for butterfly children on the list of medicines, which was supported by a petition from as many as 45,000 citizens.
The Croatian Health Insurance Institute's (HZZO) Medicines Committee will consider on Tuesday, November 10, a request to include gene therapy for the treatment of children with epilepsy on the HZZO list of medicines, the availability of which is of great public interest, the Institute announced on Friday.
According to the latest available data, around 60 people in Croatia suffer from epidermolysis bullosa (butterfly child disease), and six children could be candidates for treatment with the new gene therapy Vyjuvek.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
